Radiotherapy quality assurance in the TROG 12.01 randomised trial and its impact on loco-regional failure

Radiotherapy quality assurance in the TROG 12.01 randomised trial and its impact on loco-regional failure

IntroductionThere is no consensus as to what specifically constitutes head and neck cancer radiotherapy quality assurance (HNC RT QA). The aims of this study are to (1) describe the RT QA processes used in the TROG 12.01 study, (2) review the RT QA processes undertaken for all patients with loco-reg...

Full description

Bibliographic Details
Main Authors: June Corry, Alisha Moore, Liz Kenny, Chris Wratten, Tsien Fua, Charles Lin, Sandro Porceddu, Chen Liu, Michael Ruemelin, Amy Sharkey, Lachlan McDowell, Dean Wilkinson, Albert Tiong, Danny Rischin
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Oncology
Subjects:
quality assurance
intensity modulated radiotherapy (IMRT)
radiotherapy
head and neck (H&N) cancer
human papilloma virus - HPV
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1333098/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1333098/full

Similar Items